Pharmacy DailyPharmacy Daily | NSAID labelling appropriate

OVER the counter non-steroidal anti-inflammatory drugs (NSAID) taken in low doses for short periods of time do not increase the risk of cardiovascular events, a new study published in PLoS Medicine has found. These results, according to the Australian Self-Medication Industry, reaffirm the current labelling of various NSAID products in Australia. “While there are some limitations to the study, including its reliance on observational studies, it does shine a light on some risks associated with these products, and in particular the relationship between higher doses and increased risk,” said ASMI Regulatory and Scientific Affairs Director, Steven Scarff. Findings in the study included that both ibuprofen and naproxen did not increase cardiovascular risk when used in low doses for short periods. The study did however find that prescription doses of Diclofenac were associated with an increased cardiovascular risk. “Diclofenac is a common antiinflammatory medicine and has been in use for many years,” said Scarff. “Anyone who is in a high risk category such as people with heart problems should, as with any medication, consult their GP or pharmacist before using any medicines,” he added. In light of the findings ASMI also reminded Australians to always take note of label warnings and to strictly follow all the directions.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 29 Sep 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Sep 11